China Emerging as Vital Point of Care (POC) Market
Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information. China’s potential as a point of care (POC) market was already growing when the coronavirus […]